AKT1 and atopic eczema: The activation of calcium, CaSR, and the PLC/PI3K/PKC/Akt signaling pathways would be effectively modulated by agents for the treatment of chronic wounds and differentiation-defective skin conditions, such as psoriasis or atopic dermatitis.